Skip to main content

Advertisement

Log in

Glial Fibrillary Acidic Protein Expression Helps Distinguish Pleomorphic Adenoma from Histologic Mimics

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Pleomorphic adenoma (PA) is the most common biphasic type of salivary gland tumour to arise in adults. It is a biphasic tumour composed of both luminal (ductal) cells and abluminal (basal and myoepithelial) cells. Other biphasic salivary gland type tumours, both benign and malignant, can mimic PA, especially on small biopsies. Previous studies have shown that glial fibrillary acidic protein (GFAP) is preferentially expressed in PA and can be useful in the distinction from other salivary gland tumours. However, most of these studies were performed on a small subset of tumour types at a time when the classification of salivary gland type tumours was less refined. The purpose of this study was to assess the expression of glial fibrillary acidic protein (GFAP) in a broad group of both benign and malignant salivary gland tumours. The expression of GFAP was assessed in 99 tumours including 54 PAs, 5 basal cell adenomas, 1 myoepitheliomas, 5 adenoid cystic carcinomas, 6 epithelial-myoepithelial carcinomas (EMCA), 6 mucoepidermoid carcinomas, 7 salivary duct carcinomas, 1 adenocarcinomas NOS, 2 myoepithelial carcinomas, 4 basal cell adenocarcinomas, 5 acinic cell carcinomas and 3 polymorphous adenocarcinomas. Of the malignant cases, 8 were classified as carcinomas ex PA. GFAP was also assessed in 19 concurrent biopsy specimens. GFAP was expressed in the resections of 51 PAs examined (94%). Expression was predominantly strong and diffusely seen in myoepithelial cells. Strong and diffuse GFAP expression was also seen in two EMCAs (33%) and one myoepithelial carcinoma (50%). On biopsy specimens, 100% of PAs and basal cell adenomas expressed GFAP. GFAP was also seen in 1 out of 3 carcinomas ex PAs on biopsies. Almost all PAs show strong and diffuse expression of GFAP. In contrast, most malignant neoplasms that can mimic PA on biopsies show only rare, focal expression. Other benign tumours composed of abluminal/myoepithelial cells also show focal expression of GFAP, highlighting the spectrum these tumours share with PA. Overall, the presence of strong and diffuse GFAP expression can favour a benign neoplasm, specifically a PA, on limited biopsy specimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Data not available.

References

  1. Nagao T, Sato E, Inoue R, et al. Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice. Acta Histochem Cytochem. 2012;45(5):269–82. https://doi.org/10.1267/ahc.12019.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Tarakji B, Baroudi K, Hanouneh S, Kharma MY, Nassani MZ, Azzeghaiby SN. Extensive review in the detection of the malignant transformation of pleomorphic adenoma. Gulf J Oncolog. 2013;1(13):67–82.

    CAS  PubMed  Google Scholar 

  3. Francesco G, Emanuele C, Gabriele M, Valeria M, Angelo S, Antonio T. Myoepithelial carcinoma ex pleomorphic adenoma of the maxillary sinus: a case report and review of literature. Head Neck Pathol. 2021;15(4):1345–9. https://doi.org/10.1007/s12105-020-01282-5.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Toluie S, Thompson LD. Sinonasal tract adenoid cystic carcinoma ex-pleomorphic adenoma: a clinicopathologic and immunophenotypic study of 9 cases combined with a comprehensive review of the literature. Head Neck Pathol. 2012;6(4):409–21. https://doi.org/10.1007/s12105-012-0381-4.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Altunpulluk MD, Karabulut MH, Kır G, Şahin Ş. Pleomorphic adenoma of the larynx. North Clin Istanb. 2016;3(1):67–70. https://doi.org/10.14744/nci.2015.47965.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cantley RL. Fine-needle aspiration cytology of cellular basaloid neoplasms of the salivary gland. Arch Pathol Lab Med. 2019;143(11):1338–45. https://doi.org/10.5858/arpa.2019-0327-RA.

    Article  CAS  PubMed  Google Scholar 

  7. Zaib N, Mushtaq S, Mamoon N, Akhter N, Ayaz B. Immunohistochemical pattern of pleomorphic adenoma, polymorphous low grade adenocarcinoma and adenoid cystic carcinoma in minor salivary glands. J Dent (Tehran). 2014;11(1):38–46.

    Google Scholar 

  8. Curran AE, Allen CM, Beck FM, Damm DD, Murrah VA. Distinctive pattern of glial fibrillary acidic protein immunoreactivity useful in distinguishing fragmented pleomorphic adenoma, canalicular adenoma and polymorphous low grade adenocarcinoma of minor salivary glands. Head Neck Pathol. 2007;1(1):27–32. https://doi.org/10.1007/s12105-007-0003-8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Yang Z, Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38(6):364–74. https://doi.org/10.1016/j.tins.2015.04.003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ostrzega N, Cheng L, Layfield L. Glial fibrillary acid protein immunoreactivity in fine-needle aspiration of salivary gland lesions: a useful adjunct for the differential diagnosis of salivary gland neoplasms. Diagn Cytopathol. 1989;5(2):145–9. https://doi.org/10.1002/dc.2840050207.

    Article  CAS  PubMed  Google Scholar 

  11. Stead RH, Qizilbash AH, Kontozoglou T, Daya AD, Riddell RH. An immunohistochemical study of pleomorphic adenomas of the salivary gland: glial fibrillary acidic protein-like immunoreactivity identifies a major myoepithelial component. Hum Pathol. 1988;19(1):32–40. https://doi.org/10.1016/s0046-8177(88)80313-7.

    Article  CAS  PubMed  Google Scholar 

  12. Nishimura T, Furukawa M, Kawahara E, Miwa A. Differential diagnosis of pleomorphic adenoma by immunohistochemical means. J Laryngol Otol. 1991;105(12):1057–60. https://doi.org/10.1017/s0022215100118183.

    Article  CAS  PubMed  Google Scholar 

  13. Ianez RF, Buim ME, Coutinho-Camillo CM, Schultz R, Soares FA, Lourenço SV. Human salivary gland morphogenesis: myoepithelial cell maturation assessed by immunohistochemical markers. Histopathology. 2010;57(3):410–7. https://doi.org/10.1111/j.1365-2559.2010.03645.x.

    Article  PubMed  Google Scholar 

  14. Acharya S, Padmini S, Koneru A, Krishnapillai R. Intraoral salivary duct carcinoma: a case report and a brief review. J Oral Maxillofac Pathol. 2014;18(Suppl 1):121–7. https://doi.org/10.4103/0973-029X.141353.

    Article  Google Scholar 

  15. Xie S, Yang H, Bredell M, et al. Salivary duct carcinoma of the parotid gland: a case report and review of the literature. Oncol Lett. 2015;9(1):371–4. https://doi.org/10.3892/ol.2014.2655.

    Article  PubMed  Google Scholar 

  16. Seethala RR. Basaloid/blue salivary gland tumors. Mod Pathol. 2017;30(s1):84–95. https://doi.org/10.1038/modpathol.2016.190.

    Article  Google Scholar 

  17. Seethala RR, Stenman G. Update from the 4th edition of the world health organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol. 2017;11(1):55–67. https://doi.org/10.1007/s12105-017-0795-0.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Wilson TC, Robinson RA. Basal cell adenocarcinoma and basal cell adenoma of the salivary glands: a clinicopathological review of seventy tumors with comparison of morphologic features and growth control indices. Head Neck Pathol. 2015;9(2):205–13. https://doi.org/10.1007/s12105-014-0562-4.

    Article  PubMed  Google Scholar 

  19. Griffith CC, Siddiqui MT, Schmitt AC. Ancillary testing strategies in salivary gland aspiration cytology: a practical pattern-based approach. Diagn Cytopathol. 2017;45(9):808–19. https://doi.org/10.1002/dc.23715.

    Article  PubMed  Google Scholar 

  20. Griffith CC, Pai RK, Schneider F, et al. Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification. Am J Clin Pathol. 2015;143(6):839–53. https://doi.org/10.1309/AJCPMII6OSD2HSJA.

    Article  PubMed  Google Scholar 

  21. Xu B, Mneimneh W, Torrence DE, et al. Misinterpreted myoepithelial carcinoma of salivary gland: a challenging and potentially significant pitfall. Am J Surg Pathol. 2019;43(5):601–9. https://doi.org/10.1097/PAS.0000000000001218.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wang C, Zhang Z, Ge Y, et al. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 29 patients. J Oral Maxillofac Surg. 2015;73(10):1938–45. https://doi.org/10.1016/j.joms.2015.03.054.

    Article  PubMed  Google Scholar 

  23. Xu B, Katabi N. Myoepithelial carcinoma. Surg Pathol Clin. 2021;14(1):67–73. https://doi.org/10.1016/j.path.2020.09.008.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Chowsilpa S, An D, Maleki Z. Adenoid cystic carcinoma cytology: salivary gland and nonsalivary gland. Diagn Cytopathol. 2020;48(12):1282–9. https://doi.org/10.1002/dc.24573.

    Article  PubMed  Google Scholar 

  25. Jain R, Gupta R, Kudesia M, Singh S. Fine needle aspiration cytology in diagnosis of salivary gland lesions: a study with histologic comparison. Cytojournal. 2013;10:5. https://doi.org/10.4103/1742-6413.109547.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Zhu S, Schuerch C, Hunt J. Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors. Arch Pathol Lab Med. 2015;139(1):55–66. https://doi.org/10.5858/arpa.2014-0167-RA.

    Article  PubMed  Google Scholar 

  27. Vázquez A, Patel TD, D’Aguillo CM, et al. Epithelial-myoepithelial carcinoma of the salivary glands: an analysis of 246 cases. Otolaryngol Head Neck Surg. 2015;153(4):569–74. https://doi.org/10.1177/0194599815594788.

    Article  PubMed  Google Scholar 

  28. El Hallani S, Udager AM, Bell D, et al. Epithelial-myoepithelial carcinoma: frequent morphologic and molecular evidence of preexisting pleomorphic adenoma, common HRAS mutations in PLAG1-intact and HMGA2-intact cases, and occasional TP53, FBXW7, and SMARCB1 alterations in high-grade cases. Am J Surg Pathol. 2018;42(1):18–27. https://doi.org/10.1097/PAS.0000000000000933.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kusafuka K, Yamashita M, Muramatsu A, Arai K, Suzuki M. Epithelial-myoepithelial carcinoma ex-pleomorphic adenoma of the parotid gland: report of a rare case with immunohistochemical and genetic analyses. Med Mol Morphol. 2021;54(2):173–80. https://doi.org/10.1007/s00795-020-00262-6.

    Article  CAS  PubMed  Google Scholar 

  30. Russo D, Di Crescenzo RM, Varricchio S, et al. Low-grade intraductal carcinoma of the parotid gland: a case report and literature review. Head Neck Pathol. 2021;15(4):1359–71. https://doi.org/10.1007/s12105-021-01290-z.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Kuo YJ, Weinreb I, Perez-Ordonez B. Low-grade salivary duct carcinoma or low-grade intraductal carcinoma? Review of the literature. Head Neck Pathol. 2013;7(Suppl 1):59–67. https://doi.org/10.1007/s12105-013-0460-1.

    Article  PubMed Central  Google Scholar 

  32. Okano K, Ishida M, Sandoh K, Fujisawa T, Iwai H, Tsuta K. Cytological features of carcinoma ex pleomorphic adenoma of the salivary glands: a diagnostic challenge. Diagn Cytopathol. 2020;48(2):149–53. https://doi.org/10.1002/dc.24333.

    Article  PubMed  Google Scholar 

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

All authors made substantial contributions to the conception or design of the work; acquisition, analysis, and interpretation of data; drafted the manuscript; approved the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions.

Corresponding author

Correspondence to Jason K. Wasserman.

Ethics declarations

Conflict of interest

The authors have no conflicts or competing interests.

Ethical Approval

This study was conducted as part of a quality assurance program and was not subject to ethics approval.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gorski, Z., Purgina, B. & Wasserman, J.K. Glial Fibrillary Acidic Protein Expression Helps Distinguish Pleomorphic Adenoma from Histologic Mimics. Head and Neck Pathol 16, 695–702 (2022). https://doi.org/10.1007/s12105-021-01409-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-021-01409-2

Keywords

Navigation